BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sato M, Tateishi R, Yasunaga H, Horiguchi H, Yoshida H, Matsuda S, Koike K. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol 2012;47:1125-33. [DOI: 10.1007/s00535-012-0569-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhao C, Pei S-, Cucchetti A, Tong T-, Ma Y-, Zhong J-, Li L-. Retracted: Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma. Aliment Pharmacol Ther 2017;46:83-83. [DOI: 10.1111/apt.14044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Kim H, Lee SJ, Yoon M. Alpha-fetoprotein is correlated with intrahepatic recurrence of hepatocellular carcinoma after a hepatectomy. Ann Surg Treat Res 2020;98:168-76. [PMID: 32274364 DOI: 10.4174/astr.2020.98.4.168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Ejaz A, Spolverato G, Kim Y, Lucas DL, Lau B, Weiss M, Johnston FM, Kheng M, Hirose K, Wolfgang CL, Haut E, Pawlik TM. Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg 2014;18:1116-24. [PMID: 24337986 DOI: 10.1007/s11605-013-2432-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
4 Choi SW, Shin WY, Lee KY, Ahn SI. Risk factors of postoperative ascites on hepatic resection for hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg 2016;20:153-8. [PMID: 28261693 DOI: 10.14701/ahbps.2016.20.4.153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
5 Lei P, Ruan Y, Tan L, Wei H, Chen T. Laparoscopic colorectal resection combined with simultaneous thermal ablation or surgical resection of liver metastasis: a retrospective comparative study. Int J Hyperthermia 2020;37:137-43. [PMID: 31986941 DOI: 10.1080/02656736.2020.1716086] [Reference Citation Analysis]
6 Mulé S, Colosio A, Cazejust J, Kianmanesh R, Soyer P, Hoeffel C. Imaging of the postoperative liver: review of normal appearances and common complications. Abdom Imaging 2015;40:2761-76. [PMID: 26023007 DOI: 10.1007/s00261-015-0459-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 Yang P, Liu C, Hsu Y, Chen C, Lee C, Cheng S. A Novel Prediction Model for Bloodstream Infections in Hepatobiliary–Pancreatic Surgery Patients. World J Surg 2019;43:1294-302. [DOI: 10.1007/s00268-018-04903-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Feng K, Yan J, Li X, Xia F, Ma K, Wang S, Bie P, Dong J. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012;57:794-802. [PMID: 22634125 DOI: 10.1016/j.jhep.2012.07.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Fujiwara N, Tateishi R, Kondo M, Minami T, Mikami S, Sato M, Uchino K, Enooku K, Masuzaki R, Nakagawa H. Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablation. Eur J Gastroenterol Hepatol. 2014;26:1039-1046. [PMID: 25051219 DOI: 10.1097/meg.0000000000000161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
10 Mima K, Nakagawa S, Sawayama H, Ishimoto T, Imai K, Iwatsuki M, Hashimoto D, Baba Y, Yamashita YI, Yoshida N, Chikamoto A, Baba H. The microbiome and hepatobiliary-pancreatic cancers.Cancer Lett. 2017;402:9-15. [PMID: 28527946 DOI: 10.1016/j.canlet.2017.05.001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 11.4] [Reference Citation Analysis]
11 Erten O, Li P, Gokceimam M, Akbulut S, Berber E. Impact of ablation algorithm versus tumor-dependent parameters on local control after microwave ablation of malignant liver tumors. J Surg Oncol 2021;123:179-86. [PMID: 32976655 DOI: 10.1002/jso.26237] [Reference Citation Analysis]
12 Sanjeevi S, Sparrelid E, Gilg S, Jonas E, Isaksson B. High incidence of biliary stricture after associating liver partition and portal vein ligation for staged hepatectomy. ANZ J Surg 2018;88:760-4. [PMID: 29239077 DOI: 10.1111/ans.14252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Shen X, Ma S, Tang X, Wang T, Qi X, Chi J, Wang Z, Cui D, Zhang Y, Li P, Zhai B. Clinical outcome in elderly Chinese patients with primary hepatocellular carcinoma treated with percutaneous microwave coagulation therapy (PMCT): A Strobe-compliant observational study. Medicine (Baltimore) 2018;97:e11618. [PMID: 30170369 DOI: 10.1097/MD.0000000000011618] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
14 Chen L, Wang YB, Zhang YH, Gong JF, Li Y. Effective prediction of postoperative complications for patients after open hepatectomy: a simplified scoring system based on perioperative parameters. BMC Surg 2019;19:128. [PMID: 31488117 DOI: 10.1186/s12893-019-0597-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Imai K, Beppu T, Chikamoto A, Mima K, Okabe H, Hayashi H, Nitta H, Ishiko T, Baba H. Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy: Salvage for local recurrence of HCC. Hepatol Res 2014;44:E335-45. [DOI: 10.1111/hepr.12313] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhi Q, Zhu J, Guo X, He S, Xue X, Zhou J, Hu B, Li H, Chen S, Zhao H. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage. Biomed Pharmacother. 2013;67:393-398. [PMID: 23648054 DOI: 10.1016/j.biopha.2013.03.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
17 Xu C, Zheng H, Shi T, Qi J, Zhao X, Li J, Feng Y, Zhu Q. A prediction model of major complications after radiofrequency ablation for recurrent hepatocellular carcinoma patients. Eur J Radiol 2021;140:109635. [PMID: 34024632 DOI: 10.1016/j.ejrad.2021.109635] [Reference Citation Analysis]
18 Halls MC, Cipriani F, Berardi G, Barkhatov L, Lainas P, D'Hondt M, Rotellar F, Dagher I, Aldrighetti L, Troisi RI, Edwin B, Hilal MA. Response: "Conversion During Laparoscopic Liver Resections: a Step Forward". Ann Surg 2018;268:e81-2. [PMID: 29401109 DOI: 10.1097/SLA.0000000000002690] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Sato M, Tateishi R, Yasunaga H, Matsui H, Horiguchi H, Fushimi K, Koike K. Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: A nationwide survey. J Gastroenterol Hepatol. 2017;32:1873-1878. [PMID: 28266772 DOI: 10.1111/jgh.13780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 Lepere V, Vanier A, Loncar Y, Lemoine L, Vaillant JC, Monsel A, Savier E, Coriat P, Eyraud D. Risk factors for pulmonary complications after hepatic resection: role of intraoperative hemodynamic instability and hepatic ischemia. BMC Anesthesiol 2017;17:84. [PMID: 28633644 DOI: 10.1186/s12871-017-0372-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
21 van Rosmalen BV, Coelen RJS, Bieze M, van Delden OM, Verheij J, Dejong CHC, van Gulik TM. Systematic review of transarterial embolization for hepatocellular adenomas. British Journal of Surgery 2017;104:823-35. [DOI: 10.1002/bjs.10547] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
22 Kenjo A, Miyata H, Gotoh M, Kitagawa Y, Shimada M, Baba H, Tomita N, Kimura W, Sugihara K, Mori M. Risk Stratification of 7,732 Hepatectomy Cases in 2011 from the National Clinical Database for Japan. Journal of the American College of Surgeons 2014;218:412-22. [DOI: 10.1016/j.jamcollsurg.2013.11.007] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 11.4] [Reference Citation Analysis]
23 Huang M, Shen S, Cai H, Peng Z, Chiu WHK, Li ZP, Peng B, Feng ST. Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC. Eur Radiol 2021;31:4720-30. [PMID: 33449173 DOI: 10.1007/s00330-020-07606-x] [Reference Citation Analysis]
24 Sato M, Tateishi R, Yasunaga H, Matsui H, Fushimi K, Ikeda H, Yatomi Y, Koike K. Association between hospital volume and in-hospital mortality following radiofrequency ablation for hepatocellular carcinoma. BJS Open 2017;1:50-4. [PMID: 29951606 DOI: 10.1002/bjs5.9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
25 Spaulding TP, Martin RCG 2nd. Predicting adverse events in patients undergoing hepatectomy-validation of preoperative nomogram and risk score. HPB (Oxford) 2017;19:1112-8. [PMID: 28882456 DOI: 10.1016/j.hpb.2017.08.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
26 Iida H, Aihara T, Ikuta S, Yamanaka N. Effectiveness of impedance monitoring during radiofrequency ablation for predicting popping. World J Gastroenterol 2012; 18(41): 5870-5878 [PMID: 23139602 DOI: 10.3748/wjg.v18.i41.5870] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
27 Nishikawa H, Kimura T, Kita R, Osaki Y. Treatment for hepatocellular carcinoma in elderly patients: a literature review. J Cancer 2013;4:635-43. [PMID: 24155775 DOI: 10.7150/jca.7279] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
28 Arkadopoulos N, Gemenetzis G, Danias N, Kokoropoulos P, Koukopoulou I, Bartsokas C, Kostopanagiotou G, Smyrniotis V. Cost-Effective Surgical Management of Liver Disease Amidst a Financial Crisis. World J Surg 2016;40:1695-701. [PMID: 26913735 DOI: 10.1007/s00268-016-3440-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Van Ha TG, Tullius TG Jr, Navuluri R, Millis JM, Leef JA. Percutaneous treatment of IVC obstruction due to post-resection hepatic torsion associated with IVC thrombosis. CVIR Endovasc 2019;2:14. [PMID: 32026991 DOI: 10.1186/s42155-019-0056-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Takagi K, Yagi T, Yoshida R, Umeda Y, Nobuoka D, Kuise T, Fujiwara T. Sarcopenia predicts postoperative infection in patients undergoing hepato-biliary-pancreatic surgery. International Journal of Surgery Open 2017;6:12-8. [DOI: 10.1016/j.ijso.2016.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
31 Wang L, Yue Y, Wang X, Jin H. Function and clinical potential of microRNAs in hepatocellular carcinoma. Oncol Lett. 2015;10:3345-3353. [PMID: 26788134 DOI: 10.3892/ol.2015.3759] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
32 Terayama M, Ito K, Takemura N, Inagaki F, Mihara F, Kokudo N. Preserving inferior right hepatic vein enabled bisegmentectomy 7 and 8 without venous congestion: a case report. Surg Case Rep 2021;7:101. [PMID: 33881648 DOI: 10.1186/s40792-021-01184-w] [Reference Citation Analysis]
33 Yang R, Lian H, Zhang G, Wang W, Gan W, Li X, Yan X, Zhang S, Zhao X, Guo H. Laparoscopic Radiofrequency Ablation with Intraoperative Contrast-Enhanced Ultrasonography for T1bN0M0 Renal Tumors: Initial Functional and Oncologic Outcomes. Journal of Endourology 2014;28:4-9. [DOI: 10.1089/end.2013.0397] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
34 Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317-370. [PMID: 28620797 DOI: 10.1007/s12072-017-9799-9] [Cited by in Crossref: 661] [Cited by in F6Publishing: 667] [Article Influence: 132.2] [Reference Citation Analysis]
35 Nakayama H, Takayama T, Higaki T, Okubo T, Moriguchi M, Yoshida N, Kuronuma A. Verification of inferior right hepatic vein-conserving segments 7 to 8 resection of the liver. Int Surg 2015;100:683-8. [PMID: 25875551 DOI: 10.9738/INTSURG-D-14-00183.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
36 Cui R, Wang XH, Ma C, Liu T, Cheng ZG, Han ZY, Liu FY, Yu XL, Yu J, Liang P. Comparison of Microwave Ablation and Transarterial Chemoembolization for Single-Nodule Hepatocellular Carcinoma Smaller Than 5cm: A Propensity Score Matching Analysis. Cancer Manag Res 2019;11:10695-704. [PMID: 31920380 DOI: 10.2147/CMAR.S213581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Takagi K, Umeda Y, Yoshida R, Nobuoka D, Kuise T, Fushimi T, Fujiwara T, Yagi T. The Outcome of Complex Hepato-Pancreato-Biliary Surgery for Elderly Patients: A Propensity Score Matching Analysis. Dig Surg 2019;36:323-30. [PMID: 29945139 DOI: 10.1159/000489826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
38 Sugawara G, Yokoyama Y, Ebata T, Mizuno T, Yagi T, Ando M, Nagino M. Duration of Antimicrobial Prophylaxis in Patients Undergoing Major Hepatectomy With Extrahepatic Bile Duct Resection: A Randomized Controlled Trial. Ann Surg 2018;267:142-8. [PMID: 27759623 DOI: 10.1097/SLA.0000000000002049] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
39 Mao Y, Du S, Ba J, Li F, Yang H, Lu X, Sang X, Li S, Che L, Tong J. Using Dynamic 99mT c-GSA SPECT/CT fusion images for hepatectomy planning and postoperative liver failure prediction. Ann Surg Oncol. 2015;22:1301-1307. [PMID: 25294018 DOI: 10.1245/s10434-014-4117-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
40 Liu J, Qian LX. Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer. Exp Ther Med 2014;7:897-900. [PMID: 24669247 DOI: 10.3892/etm.2014.1505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
41 Hyder O, Sachs T, Ejaz A, Spolverato G, Pawlik TM. Impact of hospital teaching status on length of stay and mortality among patients undergoing complex hepatopancreaticobiliary surgery in the USA. J Gastrointest Surg 2013;17:2114-22. [PMID: 24072683 DOI: 10.1007/s11605-013-2349-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
42 Ito K, Takemura N, Inagaki F, Mihara F, Kokudo N. Difference in treatment algorithms for hepatocellular carcinoma between world's principal guidelines. Glob Health Med. 2020;2:282-291. [PMID: 33330822 DOI: 10.35772/ghm.2020.01066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Shimada T, Maruyama H, Kondo T, Sekimoto T, Takahashi M, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Chiba T, Kanai F, Okabe S, Yoshikawa M, Yokosuka O. Clinical features and natural history of portal vein thrombosis after radiofrequency ablation for hepatocellular carcinoma in Japan. Hepatol Int 2013;7:1030-9. [DOI: 10.1007/s12072-013-9470-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
44 Borzio M, Dionigi E, Parisi G, Raguzzi I, Sacco R. Management of hepatocellular carcinoma in the elderly. World J Hepatol 2015; 7(11): 1521-1529 [PMID: 26085911 DOI: 10.4254/wjh.v7.i11.1521] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
45 Fitzmorris P, Shoreibah M, Anand BS, Singal AK. Management of hepatocellular carcinoma. J Cancer Res Clin Oncol 2015;141:861-76. [DOI: 10.1007/s00432-014-1806-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 7.4] [Reference Citation Analysis]
46 Zhang F, Wu G, Sun H, Ding J, Xia F, Li X, Ma K, Wang S, Bie P. Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: a single centre with 13 years experience. Int J Hyperthermia 2014;30:471-9. [PMID: 25314335 DOI: 10.3109/02656736.2014.961042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
47 Asaoka Y, Tateishi R, Nakagomi R, Kondo M, Fujiwara N, Minami T, Sato M, Uchino K, Enooku K, Nakagawa H. Frequency of and predictive factors for vascular invasion after radiofrequency ablation for hepatocellular carcinoma. PLoS One. 2014;9:e111662. [PMID: 25397677 DOI: 10.1371/journal.pone.0111662] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
48 Fu Y, Wu S. A commentary on "Evaluation of delayed bleeding risks associated with partial hepatectomy: A nationwide population-based propensity score matching study" (Int J Surg 2021; 90:105980). Int J Surg 2021;92:106041. [PMID: 34333140 DOI: 10.1016/j.ijsu.2021.106041] [Reference Citation Analysis]
49 Yamamoto N, Okano K, Kushida Y, Deguchi A, Yachida S, Suzuki Y. Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery. Hepatol Res. 2014;44:1062-1071. [PMID: 23957810 DOI: 10.1111/hepr.12223] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
50 Liang QC, Tian YJ, Jiang XT. Laparoscopic repair of diaphragm perforation with heart patch after microwave ablation. Saudi Med J 2016;37:320-3. [PMID: 26905357 DOI: 10.15537/smj.2016.3.13154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
51 Fukuda K, Okumura T, Abei M, Fukumitsu N, Ishige K, Mizumoto M, Hasegawa N, Numajiri H, Ohnishi K, Ishikawa H. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma. Cancer Sci. 2017;108:497-503. [PMID: 28012214 DOI: 10.1111/cas.13145] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
52 Zhang Z, Zhang H, Peng T, Li D, Xu J. Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma. Oncol Lett 2016;11:610-8. [PMID: 26870255 DOI: 10.3892/ol.2015.3957] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
53 Park SA, Tomimaru Y, Shibata A, Miyagawa S, Noguchi K, Dono K. Incidence and Risk Factors for Postoperative Delirium in Patients After Hepatectomy. World J Surg 2017;41:2847-53. [DOI: 10.1007/s00268-017-4079-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
54 Tanaka K, Matsuo K, Kawaguchi D, Murakami T, Hiroshima Y, Hirano A, Sato S, Endo I, Taguri M, Koda K. Randomized clinical trial of peritoneal lavage for preventing surgical site infection in elective liver surgery: RCT of peritoneal lavage for preventing SSI in liver surgery. J Hepatobiliary Pancreat Sci 2015;22:446-53. [DOI: 10.1002/jhbp.222] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
55 Chen R, Gan Y, Ge N, Chen Y, Ma H, Wang Y, Zhang B, Wang Y, Ye S, Luo J, Ren Z. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching: TACE versus RFA for early HCC. Journal of Gastroenterology and Hepatology 2016;31:442-9. [DOI: 10.1111/jgh.13077] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
56 Jin S, Fu Q, Wuyun G, Wuyun T. Management of post-hepatectomy complications. World J Gastroenterol 2013; 19(44): 7983-7991 [PMID: 24307791 DOI: 10.3748/wjg.v19.i44.7983] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 69] [Article Influence: 8.6] [Reference Citation Analysis]
57 Hof J, Joosten HJ, Havenga K, de Jong KP. Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer. PLoS One 2018;13:e0193385. [PMID: 29543821 DOI: 10.1371/journal.pone.0193385] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
58 Wu Y, Han M, Liu C, Liu T, Feng Y, Zou Y, Li B, Liao H. Design, synthesis, and antiproliferative activities of stapled melittin peptides. RSC Adv 2017;7:17514-8. [DOI: 10.1039/c6ra26427a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.2] [Reference Citation Analysis]
59 Braunwarth E, Primavesi F, Göbel G, Cardini B, Oberhuber R, Margreiter C, Maglione M, Schneeberger S, Öfner D, Stättner S. Is bile leakage after hepatic resection associated with impaired long-term survival? Eur J Surg Oncol 2019;45:1077-83. [PMID: 30803908 DOI: 10.1016/j.ejso.2019.02.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
60 Tsukada Y, Nakamura F, Iwamoto M, Terahara A, Higashi T. Patterns of prescribing radiotherapy and bevacizumab in nationwide practice - analysis of 101 designated cancer care hospitals in Japan. J Radiat Res 2016;57:157-63. [PMID: 26661853 DOI: 10.1093/jrr/rrv080] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Sato M, Tateishi R, Yasunaga H, Horiguchi H, Matsui H, Yoshida H, Fushimi K, Koike K. The ADOPT-LC score: a novel predictive index of in-hospital mortality of cirrhotic patients following surgical procedures, based on a national survey: Surgery for cirrhotic patients. Hepatol Res 2017;47:E35-43. [DOI: 10.1111/hepr.12719] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
62 Maeda M, Saeki I, Sakaida I, Aikata H, Araki Y, Ogawa C, Kariyama K, Nouso K, Kitamoto M, Kobashi H, Sato S, Shibata H, Joko K, Takaki S, Takabatake H, Tsutsui A, Takaguchi K, Tomonari T, Nakamura S, Nagahara T, Hiraoka A, Matono T, Koda M, Mandai M, Mannami T, Mitsuda A, Moriya T, Yabushita K, Tani J, Yagi T, Yamasaki T. Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients. Liver Cancer. 2020;9:50-62. [PMID: 32071909 DOI: 10.1159/000502744] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
63 Kinoshita A, Koike K, Nishino H. Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resection. Geriatr Gerontol Int 2017;17:189-201. [PMID: 26847184 DOI: 10.1111/ggi.12747] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
64 Komatsu S, Kido M, Tanaka M, Kuramitsu K, Tsugawa D, Awazu M, Gon H, Toyama H, Ueno K, Fukumoto T. Clinical Relevance of Reductive Hepatectomy for Barcelona Clinic Liver Cancer Stages B and C Advanced Hepatocellular Carcinoma: A Single-Center Experience of 102 Patients.World J Surg. 2019;43:2571-2578. [PMID: 31222640 DOI: 10.1007/s00268-019-05052-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
65 Brunot A, Le Sourd S, Pracht M, Edeline J. Hepatocellular carcinoma in elderly patients: challenges and solutions. J Hepatocell Carcinoma. 2016;3:9-18. [PMID: 27574587 DOI: 10.2147/jhc.s101448] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
66 Liang YJ, Yu H, Feng G, Zhuang L, Xi W, Ma M, Chen J, Gu N, Zhang Y. High-Performance Poly(lactic-co-glycolic acid)-Magnetic Microspheres Prepared by Rotating Membrane Emulsification for Transcatheter Arterial Embolization and Magnetic Ablation in VX2 Liver Tumors. ACS Appl Mater Interfaces 2017;9:43478-89. [PMID: 29116741 DOI: 10.1021/acsami.7b14330] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
67 Kornberg A, Friess H. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches. Therap Adv Gastroenterol 2019;12:1756284819836205. [PMID: 30915167 DOI: 10.1177/1756284819836205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Sundén M, Hermansson C, Taflin H, Andersson A, Sund M, Hemmingsson O. Surgical treatment of breast cancer liver metastases - A nationwide registry-based case control study. Eur J Surg Oncol 2020;46:1006-12. [PMID: 32098734 DOI: 10.1016/j.ejso.2020.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Ueno M, Nakai T, Hayashi M, Hirokawa F, Nagano H, Wada H, Kaibori M, Matsui K, Tanaka S, Yamaue H, Kubo S. Survival outcome of salvage hepatectomy in patients with local, recurrent hepatocellular carcinoma who underwent radiofrequency ablation as their first treatment. Surgery 2016;160:661-70. [PMID: 27267547 DOI: 10.1016/j.surg.2016.04.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Azumi M, Suda T, Terai S, Akazawa K. Prognostic Impact of Indocyanine Green Plasma Disappearance Rate in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: A Prognostic Nomogram Study. Intern Med 2017;56:1001-7. [PMID: 28458303 DOI: 10.2169/internalmedicine.56.7278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]